Hara, F., Yonemori, K., Ono, M., Ueno, T., Kotani, H., Yamashita, T., Nakayama, T., Sasada, S., Bando, H., Takahashi, Y., Watanabe, K., Miyashita, M., Yasojima, H., Takayama, S., Kitano, S., Sasaki, K., Nakamura, K., Saji, S., Shien, T., Iwata, H. (2026). Paclitaxel plus bevacizumab with or without atezolizumab for hormone receptor-positive/HER2-negative advanced breast cancer: JCOG1919E (AMBITION) phase III trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1019